MGNX Insider Transactions — Page 2
162 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–162; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Risser Eric Blasius | Sr VP & Chief Business Officer | 2018-02-28 | Sale | 1,000.0 | $25.01 |
| Cilinski Lynn | VP, Controller and Treasurer | 2018-02-28 | Sale | 23,967.0 | $25.01 |
| Risser Eric Blasius | Sr VP & Chief Business Officer | 2018-01-24 | Sale | 3,000.0 | $22.5 |
| Risser Eric Blasius | Sr VP & Chief Business Officer | 2018-01-24 | Sale | 3,000.0 | $22.5 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2018-01-17 | Sale | 2,524.0 | $20.0 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2018-01-16 | Sale | 2,476.0 | $20.0 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2017-11-21 | Sale | 5,000.0 | $20.0 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2017-10-25 | Sale | 10,000.0 | $20.0 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2017-06-05 | Sale | 5,000.0 | $20.0 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2017-04-19 | Sale | 15,000.0 | $20.0 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2016-10-03 | Sale | 10,000.0 | $29.34 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2016-10-03 | Sale | 10,000.0 | $29.34 |
| Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | 2016-10-03 | Sale | 10,000.0 | $29.34 |
| Cilinski Lynn | VP, Controller and Treasurer | 2016-10-03 | Sale | 6,231.0 | $29.28 |
| Wigginton Jon Marc | Sr VP Clinical Dev & CMO | 2016-08-01 | Sale | 20,000.0 | $30.78 |
| Wigginton Jon Marc | Sr VP Clinical Dev & CMO | 2016-07-01 | Sale | 5,000.0 | $27.22 |
| Cilinski Lynn | VP, Controller and Treasurer | 2016-07-01 | Sale | 8,922.0 | $27.22 |
| Cilinski Lynn | VP, Controller and Treasurer | 2016-05-27 | Sale | 5,000.0 | $25.0 |
| Costa Paulo F | Director | 2016-03-03 | Purchase | 10,000.0 | $17.2 |
| Wigginton Jon Marc | Sr VP, Clinical | 2016-01-04 | Sale | 10,000.0 | $29.64 |
| Cilinski Lynn | VP, Controller and Treasurer | 2015-11-23 | Sale | 1,921.0 | $35.0 |
| Cilinski Lynn | VP, Controller and Treasurer | 2015-11-23 | Sale | 3,815.0 | $35.0 |
| Cilinski Lynn | VP, Controller and Treasurer | 2015-11-23 | Sale | 1,185.0 | $35.0 |
| Bonvini Ezio | Senior VP, Research | 2015-11-16 | Sale | 3,117.0 | $31.44 |
| Bonvini Ezio | Senior VP, Research | 2015-10-15 | Sale | 6,233.0 | $25.21 |
| Wigginton Jon Marc | Sr VP, Clinical | 2015-10-01 | Sale | 5,000.0 | $21.11 |
| Wigginton Jon Marc | Sr VP, Clinical | 2015-10-01 | Sale | 5,000.0 | $21.11 |
| Wigginton Jon Marc | Sr VP, Clinical | 2015-08-03 | Sale | 10,000.0 | $37.15 |
| Wigginton Jon Marc | Sr VP, Clinical | 2015-08-03 | Sale | 10,000.0 | $37.15 |
| Bonvini Ezio | Senior VP, Research | 2015-07-10 | Sale | 2,400.0 | $38.09 |
| Cilinski Lynn | VP, Controller and Treasurer | 2015-07-01 | Sale | 1,921.0 | $37.15 |
| Cilinski Lynn | VP, Controller and Treasurer | 2015-07-01 | Sale | 5,000.0 | $37.15 |
| Wigginton Jon Marc | Sr VP, Clinical | 2015-07-01 | Sale | 5,000.0 | $37.15 |
| Bonvini Ezio | Senior VP, Research | 2015-06-30 | Sale | 6,497.0 | $38.07 |
| Bonvini Ezio | Senior VP, Research | 2015-06-24 | Sale | 6,097.0 | $38.08 |
| Bonvini Ezio | Senior VP, Research | 2015-06-24 | Sale | 6,097.0 | $38.08 |
| Bonvini Ezio | Senior VP, Research | 2015-06-23 | Sale | 13,054.0 | $38.14 |
| Bonvini Ezio | Senior VP, Research | 2015-06-23 | Sale | 13,054.0 | $38.14 |
| Cilinski Lynn | VP, Controller and Treasurer | 2015-06-15 | Sale | 5,700.0 | $35.0 |
| Cilinski Lynn | VP, Controller and Treasurer | 2015-06-15 | Sale | 5,000.0 | $35.0 |
| Bonvini Ezio | Senior VP, Research | 2015-06-15 | Sale | 6,233.0 | $34.01 |
| Bonvini Ezio | Senior VP, Research | 2015-05-15 | Sale | 6,233.0 | $30.24 |
| Bonvini Ezio | Senior VP, Research | 2015-04-15 | Sale | 6,233.0 | $33.98 |
| Wigginton Jon Marc | Sr VP, Clinical | 2015-04-01 | Sale | 5,000.0 | $30.86 |
| Wigginton Jon Marc | Sr VP, Clinical | 2015-02-02 | Sale | 5,000.0 | $31.04 |
| Stein Kathryn E | SVP, Product Dev. & Regulatory | 2014-12-22 | Sale | 10,946.0 | $37.0 |
| Risser Eric Blasius | VP, Business Development | 2014-12-18 | Sale | 10,000.0 | $33.5 |
| Stein Kathryn E | SVP, Product Dev. & Regulatory | 2014-12-18 | Sale | 10,946.0 | $33.0 |
| Risser Eric Blasius | VP, Business Development | 2014-11-24 | Sale | 10,000.0 | $27.75 |
| Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 2014-11-21 | Sale | 10,946.0 | $27.0 |
| Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 2014-11-17 | Sale | 2,090.0 | $22.95 |
| Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 2014-11-14 | Sale | 23,211.0 | $23.33 |
| Risser Eric Blasius | VP, Business Development | 2014-11-13 | Sale | 10,000.0 | $25.0 |
| Risser Eric Blasius | VP, Business Development | 2014-11-12 | Sale | 15,000.0 | $23.0 |
| Wigginton Jon Marc | Sr V.P., Clinical | 2014-10-01 | Sale | 5,000.0 | $20.48 |
| Risser Eric Blasius | VP, Business Development | 2014-09-02 | Sale | 8,316.0 | $20.89 |
| Wigginton Jon Marc | Senior VP, Clinical Dev. | 2014-08-18 | Sale | 5,000.0 | $20.52 |
| Risser Eric Blasius | VP, Business Development | 2014-06-30 | Sale | 8,000.0 | $21.84 |
| Stein Kathryn E | Senior VP, Prd Dev & Reg Aff | 2014-05-29 | Sale | 10,946.0 | $19.75 |
| HURWITZ EDWARD | Director | 2014-02-18 | Sale | 308,513.0 | $36.5 |
| ORONSKY ARNOLD L | Director | 2014-02-18 | Sale | 200,000.0 | $36.5 |
| Galbraith Kenneth | Director | 2013-10-16 | Purchase | 46,875.0 | $16.0 |